ConductScience.org, home

Paper21285992

Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy.

Yun J and 10 others. Br J Cancer, 2011. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy. Papers, record 21285992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21285992

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy.
PubMed
Journal
Br J Cancer
PubMed
Year
2011
PubMed
Publication types
Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
1.19
iCite
Revised in PubMed
2021-10-20
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yun JJ
2Kim KHK H
3Kang ESE S
4Gwak GYG-Y
5Choi MSM S
6Lee JEJ E
7Nam SJS J
8Yang JHJ-H
9Park YHY H
10Ahn JSJ S
11Im YHY-H

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Breast NeoplasmsMajor topic
CarcinomaMajor topic
Hepatitis BMajor topic
LamivudineMajor topic
Adult
Aged
Algorithms
Anthracyclines
Antibiotic Prophylaxis
Antibiotics, Antineoplastic
Antiviral Agents
Case-Control Studies
Chemotherapy, Adjuvant
Combined Modality Therapy
Disease Progression
Female
Humans
Incidence
Middle Aged
Postoperative Complications
Retrospective Studies

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114990649Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.J Clin Oncol2004https://conductscience.org/library/papers/14990649PubMed
219714720Chronic hepatitis B: update 2009.Hepatology2009https://conductscience.org/library/papers/19714720PubMed
310789823Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.Drug Saf2000https://conductscience.org/library/papers/10789823PubMed
411722410Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.Br J Haematol2001https://conductscience.org/library/papers/11722410PubMed
516861051Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention.Clin Gastroenterol Hepatol2006https://conductscience.org/library/papers/16861051PubMed
612794717Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study.J Med Virol2003https://conductscience.org/library/papers/12794717PubMed
712473512Chemotherapy for metastatic breast cancer-report of a European expert panel.Lancet Oncol2002https://conductscience.org/library/papers/12473512PubMed
83049953A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.J Clin Oncol1988https://conductscience.org/library/papers/3049953PubMed
91983820Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.Gastroenterology1991https://conductscience.org/library/papers/1983820PubMed
103618581Hepatitis B virus infection in Chinese families in Hong Kong.Am J Epidemiol1987https://conductscience.org/library/papers/3618581PubMed
1120037275Current status of liver diseases in Korea: hepatitis B.Korean J Hepatol2009https://conductscience.org/library/papers/20037275PubMed
129392700Hepatitis B virus infection.N Engl J Med1997https://conductscience.org/library/papers/9392700PubMed
138872324Advanced breast cancer: a randomized study of doxorubicin or mitoxantrone in combination with cyclophosphamide and vincristine.Breast Cancer Res Treat1996https://conductscience.org/library/papers/8872324PubMed
1415054446Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy.Br J Cancer2004https://conductscience.org/library/papers/15054446PubMed
1520516452American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases.J Clin Oncol2010https://conductscience.org/library/papers/20516452PubMed
162468745Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.J Clin Oncol1989https://conductscience.org/library/papers/2468745PubMed
179654535A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.N Engl J Med1998https://conductscience.org/library/papers/9654535PubMed
1814996349Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies.J Viral Hepat2004https://conductscience.org/library/papers/14996349PubMed
1919077421Oncologists and hepatitis B: a survey to determine current level of awareness and practice of antiviral prophylaxis to prevent reactivation.Chemotherapy2009https://conductscience.org/library/papers/19077421PubMed
2017256718Chronic hepatitis B.Hepatology2007https://conductscience.org/library/papers/17256718PubMed

See all 25 referencesDownload CSV of references

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
42104370Chronic hepatitis B virus infection and the risk of extrahepatic malignancies: an updated review of epidemiology, mechanisms, and clinical implications.Virol J2026https://conductscience.org/library/papers/42104370PubMed
38958900Cross-sectional study of hepatitis B virus infection in female breast cancer patients in China for the first time diagnosed.Clin Transl Oncol2025https://conductscience.org/library/papers/38958900PubMed
36765340Antiviral therapy inhibited HBV-reactivation and improved long-term outcomes in patients who underwent radiofrequency ablation for HBV-related hepatocellular carcinoma.World J Surg Oncol2023https://conductscience.org/library/papers/36765340PubMed
34834460Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.J Pers Med2021https://conductscience.org/library/papers/34834460PubMed
34368296Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy.World J Clin Cases2021https://conductscience.org/library/papers/34368296PubMed
33311896Clinical Profile and Efficacy of Antivirals in Hepatitis B Virus Reactivation, in Patients With Cancer Receiving Chemotherapy.J Clin Exp Hepatol2020https://conductscience.org/library/papers/33311896PubMed
27330792Analysis of baseline hepatitis B virus DNA levels in chronic hepatitis B patients with non-hematological malignancies prior to the initiation of cancer chemotherapy.Mol Clin Oncol2016https://conductscience.org/library/papers/27330792PubMed
27257429Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-Screened.Hepat Mon2016https://conductscience.org/library/papers/27257429PubMed
27121321Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation.Oncotarget2016https://conductscience.org/library/papers/27121321PubMed
26752138A comparison of lamivudine vs entecavir for prophylaxis of hepatitis B virus reactivation in allogeneic hematopoietic stem cell transplantation recipients: a single-institutional experience.Bone Marrow Transplant2016https://conductscience.org/library/papers/26752138PubMed
26595058Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy: A Systematic Review and Meta-analysis.Ann Intern Med2016https://conductscience.org/library/papers/26595058PubMed
26274393Risk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral Prophylaxis.PLoS One2015https://conductscience.org/library/papers/26274393PubMed
26193852
Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).
Ann Hematol2015https://conductscience.org/library/papers/26193852PubMed
26057738Prophylactic Effect of Lamivudine for Chemotherapy-Induced Hepatitis B Reactivation in Breast Cancer: A Meta-Analysis.PLoS One2015https://conductscience.org/library/papers/26057738PubMed
25658926The compliance of doctors with viral hepatitis B screening and antiviral prophylaxis in cancer patients receiving cytotoxic chemotherapy using a hospital-based screening reminder system.PLoS One2015https://conductscience.org/library/papers/25658926PubMed
25101233Immunosuppression in Patients with Chronic Hepatitis B.Curr Hepatol Rep2014https://conductscience.org/library/papers/25101233PubMed
24247262Management of patients with hepatitis B who require immunosuppressive therapy.Nat Rev Gastroenterol Hepatol2014https://conductscience.org/library/papers/24247262PubMed
24209764Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center.BMC Cancer2013https://conductscience.org/library/papers/24209764PubMed
23805156Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis.Hepat Mon2013https://conductscience.org/library/papers/23805156PubMed
23652302Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours.Br J Cancer2013https://conductscience.org/library/papers/23652302PubMed

See all 23 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
GPT2875PubTator's text mininghttps://conductscience.org/library/genes/2875NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene
SLC17A526503PubTator's text mininghttps://conductscience.org/library/genes/26503NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21285992

GET https://conductscience.org/api/papers/v1/21285992/references?page=2